Key insights and market outlook
BPJS Kesehatan has released 126.2 million rows of sample data, representing a significant expansion from previous years. The data includes contextual information on various health conditions such as diabetes, tuberculosis, and mental health. This release aims to support evidence-based research and policy-making in Indonesia's healthcare sector. The data is accessible through the JKN Data Portal after registration and approval.
BPJS Kesehatan has launched an expanded version of its sample data, now containing 126.2 million data rows. This represents an increase of 23.3 million data rows from the previous year 1
The released data covers a wide range of health topics, including diabetes mellitus, tuberculosis, maternal and child health, and mental health. Notably, the 2025 release includes contextual data on COVID-19, enabling researchers to study the long-term impacts of the pandemic on healthcare utilization and costs.
To access the sample data, researchers must register through the JKN Data Portal (https://data.bpjs-kesehatan.go.id/). The registration process includes submitting a research proposal and signing a data usage agreement. BPJS Kesehatan emphasizes that data security is a top priority, with robust measures in place to protect sensitive information.
The availability of this extensive dataset is expected to significantly boost healthcare research in Indonesia. Academics, policymakers, and healthcare professionals can leverage this data to conduct meaningful studies, inform policy decisions, and ultimately improve the country's healthcare system.
While the data release is a significant step forward, experts highlight challenges such as ensuring the sustainability of the JKN program, addressing service disparities, and maintaining high service standards. Collaborative efforts between various stakeholders will be crucial in addressing these challenges and maximizing the value of the available data.
Healthcare Data Sample Release
Research Data Expansion